Asma

Global initiative for asthma. Global strategy for asthma management and prevention, 2017. Disponible en: www.ginasthma.org. [Consultado enero 2018]. GEMA 4.2. Guía española para el manejo del asma. Disponible en: www.gemasma.org. [Consultado enero 2018]. ECRHHS, 2002, The European Community Respiratory Health Survey II, Eur Respir J., 20, 1071, 10.1183/09031936.02.00046802 Grupo español del estudio europeo en asma. Estudio europeo del asma. Prevalencia de hiperreactividad bronquial y asma en jóvenes en 5 regiones de España. Med Clin (Barc). 1996;106:761-7. Pereira, 2008, Incidencia de asma en 2 etapas de la vida: niños y adultos jóvenes de la ciudad de Huelva, Arch Bronconeumol., 44, 464, 10.1016/S0300-2896(08)72115-X Barnes, 2011, Pathophysiology of allergic inflammation, Immunol Rev., 242, 31, 10.1111/j.1600-065X.2011.01020.x Levine, 2010, Narrative review: the role of Th2 immune pathway modulation in the treatment of severe asthma and its phenotypes, Ann Intern Med., 152, 232, 10.7326/0003-4819-152-4-201002160-00008 Al-Muhsen, 2011, Remodeling in asthma, J Allergy Clin Immunol., 128, 451, 10.1016/j.jaci.2011.04.047 Wenzel, 1999, Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics, Am J Respir Crit Care Med., 160, 1001, 10.1164/ajrccm.160.3.9812110 Tabatabaian, 2017, Biologics and new therapies in asthma, Immunol Allergy Clin N Am., 37, 329, 10.1016/j.iac.2017.01.007 Dweik, 2011, An official ATS Clinical Practice Guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications, Am J Respir Crit Care Med., 184, 602, 10.1164/rccm.9120-11ST Plaza, 2017, Consenso sobre el solapamiento de asma y EPOC (ACO) entre la Guía española de la EPOC (GesEPOC) y la Guía Española para el Manejo del Asma (GEMA), Arch Bronconeumol., 53, 443, 10.1016/j.arbres.2017.04.002 Kew, 2013, Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children, Cochrane Database Syst Rev., 12, CD009019 Chung, 2014, International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma, Eur Respir J., 43, 343, 10.1183/09031936.00202013 Abramson, 2003, Allergen immunotherapy for asthma, Cochrane Database Syst Rev., CD001186 Normansell, 2015, Sublingual inmunotherapy for asthma, Cochrane Database Syst Rev., CD011293 Israel, 2017, Severe and difficult-to-treat asthma in adults, N Engl J Med., 377, 965, 10.1056/NEJMra1608969 Humbert, 2014, Omalizumab in asthma: an update on recent developments, J Allergy Clin Immunol Pract., 2, 10.1016/j.jaip.2014.03.010 Arm, 2014, Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects, Clin Exp Allergy., 44, 1371, 10.1111/cea.12400 Ortega, 2014, Mepolizumab treatment in patients with severe eosinophilic asthma, N Engl J Med., 371, 1198, 10.1056/NEJMoa1403290 https://www.aemps.gob.es/medicamentosUsoHumano/informesPublicos/docs/IPT-mepolizumab-Nucala-asma EPOC.pdf. [Consultado febrero 2018]. Katial, 2017, Changing paradigms in the treatment of severe asthma: the role of biologic therapies, J Allergy Clin Immunol Pract., 5, S1, 10.1016/j.jaip.2016.11.029 Castro, 2015, Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials, Lancet Respir Med., 3, 355, 10.1016/S2213-2600(15)00042-9 Torrego, 2014, Bronchial thermoplasty for moderate or severe persistent asthma in adults, Cochrane Database of Systematic Reviews., CD009910 Gibson, 2017, Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial, Lancet., 390, 659, 10.1016/S0140-6736(17)31281-3